Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Guidelines for the management of hemophilia

Alok Srivastava, A. Brewer, Evelien P. Mauser‐Bunschoten et al. · Haemophilia · 2012 · 1.9K citations · Full text

Break‐through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe hemophilia A

P. Collins, Victor S. Blanchette, Kathelijn Fischer et al. · Journal of Thrombosis and Haemostasis · 2008 · 320 citations

Factor Viii Levels, Medicine, Hematology +7

A randomized comparison of two prophylaxis regimens and a paired comparison of on‐demand and prophylaxis treatments in hemophilia A management

Leonard A. Valentino, Vasily Mamonov, Andrzej Hellmann et al. · Journal of Thrombosis and Haemostasis · 2011 · 252 citations · Full text

Prophylaxis Treatments, Health Policy, Hematology +3

Clinical severity of haemophilia A: does the classification of the 1950s still stand?

I. E. M. DEN UIJL, E. P. Mauser Bunschoten, G. Roosendaal et al. · Haemophilia · 2011 · 236 citations

Population pharmacokinetics of recombinant factor VIII: the relationships of pharmacokinetics to age and body weight

Sven Björkman, Myungshin Oh, Gerald Spotts et al. · Blood · 2011 · 204 citations · Full text